Senores Pharmaceuticals Share Price

    NSE
    609.4
    +21.40 (3.51%)
    SENORES • 11 Jul, 2025 | 09:43 AM
    BUY
    The current prices are delayed, login or Open Demat Account for live prices.

    Senores Pharmaceuticals Stock Performance

    1W Return3.89
    1Y Return0.00
    Today's Low585.9
    Prev. Close588.00
    Mkt Cap (Cr.)2,707.95
    1M Return8.62
    3Y Return0.00
    52-Week High665
    Open588.00
    PE Ratio0.00
    6M Return17.10
    Today's High591.15
    52-Week Low435.25
    Face Value10

    Senores Pharmaceuticals Company background

    Founded in: 2017
    Managing director: SWAPNIL JATINBHAI SHAH
    Senores Pharmaceuticals Limited was originally incorporated as Senores Pharmaceuticals Private Limited through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre. Thereafter, the name of the Company was changed to Senores Pharmaceuticals Limited upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company. Senores Pharma is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for Regulated Markets across various therapeutic areas and dosage forms. The Regulated Markets business is focused on Regulated Markets of US and Canada. The Company has adopted a strategy of identifying, developing and commercializing specialty and complex niche products in the midmarket range and received approvals for 19 ANDAs. Further, it develop and manufacture pharmaceutical products across various therapeutic areas for Emerging Markets, having a presence across 43 countries. The Company operate a Critical Care Injectables Business, supplying critical care injectables to hospitals across India through distributors, and manufacture APIs for the domestic market and SAARC countries.In 2021, the Company incorporated a wholly owned subsidiary, Senores Pharmaceuticals Inc in the US. It then entered the new segment of API by acquiring Ratnagene Lifescience Private Limited. The Company started domestic business with the launch of the Critical Care Injectables Business in 2022.The Company further acquired majority stake in Havix Group Inc., making it a subsidiary of the Company in 2023. It consolidated presence in emerging markets by acquiring shares in Ratnatris Pharmaceuticals Private Limited, making it a Subsidiary of the Company in 2023. The Company has launched CMO product in the US with Jubilant Cadista Pharmaceuticals Inc., in 2024. The Company is planning to raise money from public through IPO by issue and allotment of 2,700,000 Equity Shares through Offer for Sale and Rs 500 Crores equity funds through Fresh Issue.

    As of 11 Jul, 2025, Senores Pharmaceuticals share price is ₹588.8. The stock opened at ₹588 and had closed at ₹588 the previous day. During today’s trading session, Senores Pharmaceuticals share price moved between ₹585.90 and ₹591.15, with an average price for the day of ₹588.52. Over the last 52 weeks, the stock has recorded a low of ₹435.25 and a high of ₹665.00. In terms of performance, Senores Pharmaceuticals share price has increased by 17.1% over the past six months and has increased by 3.41% over the last year.

    Read More
    View details of Market Depth

    Senores Pharmaceuticals Fundamental

    Market Cap (in crs)

    2,707.95

    Face Value

    10

    Turnover (in lacs)

    94.08

    Key Metrics

    Qtr Change %
    35.29% Gain from 52W Low
    14.2
    Dividend yield 1yr %
    0

    Senores Pharmaceuticals Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Senores Pharmaceuticals Quarterly Revenue
    Mar 2025Dec 2024Mar 2024Dec 2023
    114.21 Cr
    103.02 Cr
    214.52 Cr
    78.7 Cr
    Senores Pharmaceuticals Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022
    417.51 Cr
    217.34 Cr
    39.02 Cr
    14.63 Cr
    Senores Pharmaceuticals Quarterly Net Profit/Loss
    Mar 2025Dec 2024Mar 2024Dec 2023
    17.97 Cr
    16.43 Cr
    32.7 Cr
    7.12 Cr
    Senores Pharmaceuticals Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022
    58.34 Cr
    32.71 Cr
    8.43 Cr
    0.99 Cr

    Senores Pharmaceuticals Result Highlights

    • Senores Pharmaceuticals Ltd reported a 100.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.

    • Its expenses for the quarter were up by 119.4% QoQ and - - YoY.

    • The net profit increased 99.0% QoQ and - - YoY.

    • The earnings per share (EPS) of Senores Pharmaceuticals Ltd stood at 12.2 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Senores Pharmaceuticals

    Promoter
    45.8%
    Foreign Institutions
    4.2%
    Mutual Funds
    3.2%
    Domestic Institutions
    9.6%
    Public
    40.4%
    Promoter
    45.8%
    Foreign Institutions
    4.2%
    Mutual Funds
    5%
    Domestic Institutions
    11.8%
    Public
    38.2%

    Senores Pharmaceuticals Technical Analysis

    Moving Averages Analysis
    609.4
    Current Price
    Bullish Moving Averages
    13
    Bearish Moving Averages
    0
    5Day EMA
    583.60
    10Day EMA
    576.80
    12Day EMA
    574.10
    20Day EMA
    564.60
    26Day EMA
    559.20
    50Day EMA
    548.20
    100Day EMA
    545.40
    EMA
    5Day SMA
    581.30
    10Day SMA
    579.40
    20Day SMA
    560.70
    30Day SMA
    550.50
    50Day SMA
    534.00
    100Day SMA
    544.60
    SMA
    SMA
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    86969 Rs
    183120 Rs
    Week Rs
    117822 Rs
    266485 Rs
    Month Rs
    129465 Rs
    295439 Rs
    585.70
    Pivot
    Resistance
    First Resistance
    595.75
    Second Resistance
    603.50
    Third Resistance
    613.55
    Support
    First Support
    577.95
    Second support
    567.90
    Third Support
    560.15
    Relative Strength Index
    64.62
    Money Flow Index
    76.74
    MACD
    14.86
    MACD Signal
    12.86
    Average True Range
    21.74
    Average Directional Index
    20.96
    Rate of Change (21)
    8.47
    Rate of Change (125)
    5.73
    Name
    Holding Percent
    Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund
    1.39
    Mahindra Manulife Large & Mid Cap Fund
    1.11
    Astorne Capital Vcc - Arven
    1.83
    Aditya Birla Sun Life Insurance Company Limited
    3.71

    Senores Pharmaceuticals Latest News

    10 JUL 2025 | Thursday

    Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Acquisition

    10 JUL 2025 | Thursday

    Senores Pharmaceuticals Ltd - 544319 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    25 JUN 2025 | Wednesday

    Senores Pharmaceuticals Ltd - 544319 - Closure of Trading Window

    View More

    Senores Pharmaceuticals Share Price FAQs

    Senores Pharmaceuticals share price is ₹609.4 in NSE and ₹608.95 in BSE as on 11/7/2025.

    Senores Pharmaceuticals share price in the past 1-year return was 0. The Senores Pharmaceuticals share hit a 1-year low of Rs. 435.25 and a 1-year high of Rs. 665.

    The market cap of Senores Pharmaceuticals is Rs. 2707.95 Cr. as of 11/7/2025.

    The PE ratios of Senores Pharmaceuticals is 0 as of 11/7/2025.

    The PB ratios of Senores Pharmaceuticals is 3.82 as of 11/7/2025

    The Mutual Fund Shareholding in Senores Pharmaceuticals was 3.23% at the end of 11/7/2025.

    You can easily buy Senores Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Senores Pharmaceuticals share price is ₹665 and ₹435.25 as of 11/7/2025.

    Please be aware that Senores Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    66.10
    +0.13 (+0.20%)
    137.05
    -0.08 (-0.06%)
    694.30
    -1.30 (-0.19%)
    2,586.00
    +5.00 (+0.19%)
    161.76
    -7.88 (-4.65%)
    383.70
    -1.00 (-0.26%)
    161.04
    +0.38 (+0.24%)
    261.10
    -1.75 (-0.67%)
    412.50
    -1.00 (-0.24%)
    400.65
    +0.75 (+0.19%)
    Top Gainers
    2,513.80
    +105.40 (+4.38%)
    1,827.10
    +16.90 (+0.93%)
    1,175.00
    +10.70 (+0.92%)
    12,631.00
    +115.00 (+0.92%)
    1,098.40
    +9.50 (+0.87%)
    Top Losers
    3,322.50
    -59.50 (-1.76%)
    3,116.00
    -46.40 (-1.47%)
    261.20
    -3.85 (-1.45%)
    1,593.10
    -22.70 (-1.40%)
    329.00
    -2.65 (-0.80%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -